The Leadership Team at Excision BioTherapeutics is responsible for setting the strategic direction and vision of the company, guiding its mission to develop innovative gene-editing therapeutics. This team, comprised of the CEO, CFO, CTO, and Chief Scientific Officer, works collaboratively to ensure operational excellence, drive scientific advancements, and secure funding while fostering partnerships that enhance the company’s capabilities in addressing life-threatening viral diseases.
View all